Bleeding while on continuous combined hormone replacement therapy is one of the most common reasons women contact their HRT clinician. It is also one of the easiest concerns to misread without context. Some bleeding in the first few months is an expected part of the body settling into a new regimen, but the same symptom later on can mean something different. The key is knowing where you are in the timeline.

This article sets out what continuous combined HRT is, why bleeding happens, what is and is not typical in the first six months, when persistent or new bleeding warrants clinical review, and what clinicians can adjust if the pattern does not settle.

What "continuous combined" HRT actually means

Hormone replacement therapy is broadly divided into two regimens: cyclical (or sequential) HRT, and continuous combined HRT. The difference matters for bleeding.

Cyclical HRT delivers oestrogen every day and a progestogen for part of the month — typically 10 to 14 days. The progestogen-free interval produces a predictable monthly withdrawal bleed, similar to a light period. Cyclical regimens are normally used in perimenopause, when ovaries are still producing some hormones and a controlled monthly bleed is the realistic goal.

Continuous combined HRT, by contrast, delivers both oestrogen and a progestogen every day, with no break. The intention of this design is a bleed-free pattern. By keeping the endometrium (the lining of the uterus) under steady progestogen exposure all the time, there is no scheduled withdrawal bleed, and over time the lining typically thins and stays quiet. Continuous combined regimens are used once a woman is postmenopausal — generally after at least 12 months without a natural period, or after the perimenopausal transition is felt to be complete.

UK women on continuous combined HRT may be on a single combined product, such as Evorel Conti patches, which deliver both hormones together through the skin; or on separate oestrogen and progestogen components — for example, an oestrogen gel or patch with an oral or topical progestogen taken every day, or with a progestogen-releasing intrauterine system providing the endometrial protection. The biology behind the bleed-free goal is the same in every case.

Why bleeding can happen anyway, especially in the first 6 months

The bleed-free target is what continuous combined HRT is designed for, but biology often takes a few months to follow the plan. In the first 3 to 6 months on a new regimen, the endometrium has to adapt to constant exposure to both hormones. During that adaptation it can shed in small irregular amounts, producing spotting or light bleeding without warning. This is sometimes called breakthrough or unscheduled bleeding, and in the early window it is one of the most common things to happen on continuous combined HRT.

Several patterns can show up while the endometrium settles:

  • Light spotting that comes and goes over a few days, then disappears.
  • One or two short, light bleeds in the first few months, with longer bleed-free gaps in between.
  • A bleed that starts a few weeks after beginning HRT and tapers off over a fortnight.
  • Brown discharge rather than fresh red bleeding.

None of these patterns, on their own, mean the regimen is wrong. They mean the lining is adjusting. NICE guidance recognises this early adjustment period explicitly, and clinicians typically allow up to six months for the pattern to settle before considering investigation, provided nothing else looks unusual.

For a wider sense of how HRT establishes its effects, our guide on how long it takes for HRT to work covers the same timeline from the symptom-relief side.

Other reasons bleeding can happen on continuous HRT

The endometrium settling is the most common explanation in the early months, but it is not the only one. Several other factors can contribute to unscheduled bleeding:

Missed or inconsistent doses

Continuous combined HRT relies on steady hormone exposure. Missing patches, skipping tablets, or applying gels inconsistently can briefly drop progestogen levels and let the endometrium become unstable, producing breakthrough bleeding. Taking the regimen as prescribed — every day, no breaks — gives it the best chance of producing the bleed-free pattern.

Switching products

Changing from one HRT product to another — for example, moving from tablets to patches, or from one combined patch to a different one — often resets the adjustment clock. A short period of unscheduled bleeding after a switch is common, and is not, on its own, a sign the new regimen is wrong.

The progestogen type or route is not quite right

Some women's endometria respond well to oral progestogens, others to transdermal patches, others to the levonorgestrel intrauterine system. If bleeding does not settle on one type, a different progestogen or route may suit you better. This is a common adjustment in clinical practice and is one of the most useful tools a clinician has.

Other contributors

Bleeding can also have causes outside the HRT itself, including cervical or endometrial polyps, fibroids, cervical changes, infection, or — much less commonly — endometrial hyperplasia or cancer. These are exactly the reasons why bleeding that does not settle is investigated rather than waited out indefinitely.

What to do if bleeding starts later or doesn't settle

Two patterns deserve a particular note because they are the ones clinicians treat as red flags.

Bleeding that continues or starts new after six months on a stable regimen. Once the early adjustment window has passed, persistent unscheduled bleeding is no longer assumed to be the lining settling. NICE guidance (NG23) prompts clinicians to assess the cause, which usually means a discussion, a pelvic examination, and often a transvaginal ultrasound to measure endometrial thickness. Where the endometrium is thicker than expected, or there are other concerning features, a biopsy may be recommended. The aim is not to alarm — it is to rule out the small minority of cases where there is an endometrial cause that needs treating.

Bleeding that starts after a long bleed-free period. A woman who has been bleed-free on continuous combined HRT for a year or more, and then has new vaginal bleeding, should contact her clinician promptly. This pattern is treated as post-menopausal bleeding and is investigated as such, even if HRT is in the picture, because the same investigations are used to rule out endometrial causes.

The same applies to heavy bleeding at any point, bleeding accompanied by pelvic pain, or bleeding after sex — these are reasons to seek review rather than wait. None of these patterns means something serious is necessarily wrong, but they do mean that watchful waiting is no longer the appropriate strategy.

How clinicians adjust HRT to address bleeding

If the bleeding pattern needs addressing and serious causes have been excluded, the clinical toolkit is broad. Some of the options that come up in consultation:

  • Switching the progestogen type. Different progestogens have different effects on the endometrium. Moving from one to another, or to micronised progesterone, can settle bleeding in many women.
  • Changing the route. Moving from oral to transdermal, or from a combined patch to separate components, can change how steadily the progestogen reaches the endometrium.
  • Using a progestogen-releasing intrauterine system. A levonorgestrel intrauterine system provides direct local progestogen to the endometrium and is one of the most reliable ways to achieve and maintain a bleed-free pattern.
  • Adjusting the oestrogen dose. A higher oestrogen dose, relative to a fixed progestogen, can drive more endometrial activity and contribute to bleeding. Rebalancing the regimen can help.
  • Reviewing adherence. Sometimes the simplest answer is making the regimen easier to follow consistently — for example, switching to a once-weekly patch.

The right next step is individual. Your clinician will look at your full picture — how long you have been on HRT, what the bleeding looks like, your symptoms, your previous regimens — before recommending a change. For broader context, you can browse our women's health category for related articles on HRT and perimenopause.

The practical takeaway

Continuous combined HRT is designed to produce a bleed-free pattern, but most women need a few months for that pattern to establish, and unscheduled bleeding or spotting in the first 3 to 6 months is common and usually settles. Beyond that window, persistent or new bleeding should be assessed rather than waited out, and there are several clinical adjustments that can help.

If you are on HRT and unsure about a bleeding pattern, a useful starting point is to track the dates and character of any bleeding — light versus heavier, fresh versus brown discharge, days bleed-free in between — and to bring that record to your consultation. It makes the picture clearer and the decision about next steps faster. Your clinician will advise based on your individual circumstances and the wider context of your treatment.